CompletedNot Applicable

Treatment Protocol and Long-Term Outcomes in Craniofacial Fibrous Dysplasia

Taiwan13 participantsStarted 2020-03-01

Plain-language summary

Craniofacial fibrous dysplasia (CFD) is a nonneoplastic disease characterized by fibro-osseous lesions in the affected bones. Treatment is mainly surgical and is stratified based on four different anatomical zones. This study aimed to evaluate the long-term outcomes and refine the algorithm for CFD.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Received CFD surgical intervention between 1972 and 2019 * Personal interviews: between late 2019 and 2020, covering a postoperative period of over 20 years * All the surgery were performed by a senior surgeon (Yu-Ray Chen) at Chang Gung Craniofacial Center Exclusion Criteria: * Patients who underwent surgical treatment at other institutions during the follow-up period or those who did not return to the craniofacial outpatient department for follow-up and receive computed tomography scans between 2019 and 2020 will be excluded.

What they're measuring

Recurrence

Timeframe: Personal interviews with facial bone computed tomography obtained on late 2019 and 2020

Trial details

NCT IDNCT06167122

SponsorChang Gung Memorial Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-02-10

View on ClinicalTrials.gov More Craniofacial Fibrous Dysplasia trials